Author

Yao Xiao

University of Rochester MedicineORCID 0000-0002-4638-4148Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yao Xiao1 paper · Peking University

Biology Disciplines

Click to filter author papers

Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Chawnshang ChangiD· 1 shared Fu-Ju ChouiD· 1 shared Hui Min LiniD· 1 shared Jie ZhaoiD· 1 shared Renan Jin· 1 shared Xiujun CaiiD· 1 shared Yin SuniD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSynthetic Biology

Chawnshang ChangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Olaparib and Enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling

Jie Zhao, Yin Sun, Hui Min Lin, Fu-Ju Chou, Yao Xiao, Renan Jin, Xiujun Cai, Chawnshang Chang

This study shows that combining Olaparib and Enzalutamide synergistically suppresses HCC progression by targeting AR-mediated miR-146a-5p/BRCA1 signaling.

The FASEB Journal · Mar 5, 2020Peer-reviewedSynthetic Biology